Business & Finance
Valneva receives CEPI funding to boost access to world's first chikungunya vaccine
22 July 2024 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) and and the Coalition for Epidemic Preparedness Innovations (CEPI) announced on Monday that CEPI has awarded Valneva an add...
CVS Health announces quarterly dividend
9 July 2024 - CVS Health (NYSE: CVS), a US-based health solutions company, announced its quarterly dividend on Monday.The company declared a quarterly dividend of USD0.665 per share on the of the corp...
Emmaus Life Sciences reports 2023 financial results
4 July 2024 - Emmaus Life Sciences, Inc. (OTCPK: EMMA), a California-based commercial-stage biopharmaceutical company involved in the treatment of sickle cell disease, announced on Wednesday its finan...
Quest Diagnostics to acquire LifeLabs from OMERS for USD1.35bn
3 July 2024 - Diagnostic information services provider Quest Diagnostics (NYSE: DGX) announced on Wednesday that it has signed a definitive agreement to acquire LifeLabs, provider of community laborat...
Eli Lilly announces Q3 2024 dividend
25 June 2024 - Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Monday its dividend for the third quarter of 2024.The company has declared a dividend of US...
Valneva's chikungunya vaccine IXCHIQ approved by Health Canada
24 June 2024 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) announced on Monday that it has secured its second approval for IXCHIQ, its single-dose chikungunya vaccine.Health Canada a...